New Uses of AbobotulinumtoxinA in Aesthetics
Open Access
- 7 April 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 37 (suppl_1), S45-S58
- https://doi.org/10.1093/asj/sjx005
Abstract
BotulinumtoxinA (BoNT-A) is now widely established for the main approved indication of reducing glabellar lines, and is also widely used off-label to improve the appearance of wrinkles and lines in other parts of the face. The number of aesthetic procedures continues to increase as the patient population becomes more diverse, in particular with increasing numbers of people of color and men. Further developments in treatment may continue to expand the audience for BoNT-A by making procedures more comfortable and by delivering a more natural, less static appearance. These may be achieved through use of combinations of BoNT-A with other aesthetic procedures, tailoring the dose of toxin to the patient’s muscle mass or by using novel injection and application techniques. Beyond amelioration of facial lines, encouraging results have been seen with the use of BoNT-A to improve the appearance of hypertrophic and keloid scars and even to prevent them. Studies have been conducted with scars in various parts of the body and further research is ongoing. Dermatological and other medical uses for BoNT-A are also active areas of research. Injections of BoNT-A have been shown to reduce signs and symptoms of acne, rosacea, and psoriasis, to reduce neuromuscular pain, and to bring about significant improvements in a number of rare diseases that are caused or exacerbated by hyperhidrosis. This paper reviews these new uses for BoNT-A, looking at the rationale for their use and discussing the results of published case studies and clinical trials. These areas have shown great promise to date, but more and larger clinical studies will be required before these treatments become a clinical reality. To this end details are also provided of clinical trials currently listed in the main clinical trials database to highlight research areas of particular interest.Keywords
This publication has 92 references indexed in Scilit:
- Microbotox of the Lower Face and NeckPlastic and Reconstructive Surgery, 2015
- Combined Treatment with Botulinum Toxin and 595-nm Pulsed Dye Laser for Traumatic ScarringAnnals of Dermatology, 2015
- Botulinum Toxin to Improve Results in Cleft Lip Repair: A Double-Blinded, Randomized, Vehicle-Controlled Clinical TrialPLOS ONE, 2014
- Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findingsInternational Wound Journal, 2012
- Botulinum Toxin A for the Treatment of KeloidsSkin Pharmacology and Physiology, 2012
- Griffose faciale : traitement des rides dynamiques du visage par injections dermiques simultanées de toxine botulique A et d’acide hyaluroniqueAnnales de Chirurgie Plastique Esthétique, 2012
- Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines.2012
- Tratamento da doença de Hailey-Hailey com toxina botulínica tipo AAnais Brasileiros de Dermatologia, 2010
- Re-Engineering Clostridial Neurotoxins for the Treatment of Chronic PainBioDrugs, 2010
- Use of intradermal botulinum toxin to reduce sebum production and facial pore size.2008